Rafarma Pharmaceuticals, Inc. (RAFA) Operational Subsidiary Introduces New Board of Directors

TERBUNY, RUSSIA -- (Marketwired) -- 07/17/13 -- The pharmaceutical plant operations of Rafarma Pharmaceuticals, Inc. (OTC:…

Continue Reading

Rafarma Pharmaceuticals, Inc. (RAFA) Enters Into New Exclusive Production Contract With JSC F-Synthesis to Produce Anti-Cancer Drug Imatinib

TERBUNY, RUSSIA -- (Marketwired) -- 07/16/13 -- Rafarma Pharmaceuticals, Inc. (OTC: RAFA) announces the signing of…

Continue Reading

Rafarma Pharmaceuticals, Inc. (RAFA) Enters Into New Production Contract for Para-Aminosalicylic Acid

TERBUNY, RUSSIA -- (Marketwired) -- 07/05/13 -- Rafarma Pharmaceuticals, Inc. (OTC: RAFA) is pleased to announce…

Continue Reading